Loading

  • June 23, 2022

Is your Biomarker Strategy Up-to-Date?

Is your Biomarker Strategy Up-to-Date?

Research on neurological biomarkers is a very dynamic field. The recent FDA approval of a diagnostic test measuring the Amyloid-beta 1-42 / 1-40 ratio in CSF for Alzheimer's disease, or the breakthrough device status granted to a blood test measuring NfL levels in Multiple Sclerosis are a clear illustration of this trend.

At Active Biomarkers, we have implemented methods to detect neurological biomarkers in both CSF AND Blood matrices, using ultrasensitive immunoassays when required.

Learn more here

  • June 23, 2022

Sail safely to your new analytical method

Developing a new analytical method is just like crossing the Ocean: the Departure and Arrival are clearly marked but the journey is unknown and might change according to the weather forecast.

A TRUSTED PARTNER to stay the course is key to SUCCESS!

Lear how we can help you reach your destination

  • June 23, 2022

What is the recipe for a successful ROA?

Why is Receptor Occupancy Assay so important in the development of your biologics?

Receptor Occupancy Assay (ROA) by flow cytometry for quantitative assessment of the binding of a therapeutic agent to its cell-surface target, is valuable at each step of drug development for:

› Documenting the Mechanism of Action
 Demonstrating Target Engagement
 Correlating engagement to efficacy in vivo
 Building PK/PD models
 Anticipating potential safety issues 
 And eventually establishing optimal dosing and administration schedule

Here's what you need to consider for a successful ROA

  • November 15, 2021

Need to track circulating neurological biomarkers?

For clinical monitoring, patient stratification, documenting target engagement, leverage our ULTRASENSTITIVE and MULTIPLEX assays.

Click here to learn more

  • June 15, 2021

The Vaccine Bioanalytical Toolbox

Wanted or unwanted? Check the impact of your vaccine candidate on patients' immune system thanks to our comprehensive bioanalytical toolbox.

 

  • June 15, 2021

Ella system is Active now! ACTivate your biomarker analyses

Fast and flexible! Translate your precious and limited samples into reliable data with the Ella™ multiplex system. Just ACT!